SUBCUTANEOUS BORTEZOMIB IN PATIENTS OVER 75 YEARS WITH MULTIPLE MYELOMA

被引：0
|
作者：
Violeta, Martinez-Robles [1 ]
Belen, Ballina [1 ]
Seila, Cerda [1 ]
Filomeno, Rondon [1 ]
Natalia, De Las Heras [1 ]
Jose-Antonio, Rodriguez-Garcia [1 ]
Fernando, Escalante [1 ]
机构：
[1] Complejo Asistencial Univ Leon, Leon, Spain
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB-003
引用
收藏
页码：302 / 302
页数：1
相关论文
共 50 条
  • [1] Subcutaneous Bortezomib in Older Multiple Myeloma Patients (> 75 y/o)
    Martinez Robles, Violeta
    Ballina, Belen
    Cerda, Seila
    Gonzalez, Paola
    Rodon, Filomeno
    de las Heras, Natalia
    Antonio Rodriguez-Garcia, Jose
    Escalante, Fernando
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01) : E103 - E103
  • [2] Subcutaneous Bortezomib In Multiple Myeloma
    Hoy, Sheridan M.
    DRUGS, 2013, 73 (01) : 45 - 54
  • [3] Subcutaneous bortezomib for multiple myeloma treatment: patients' benefits
    Petrucci, Maria Teresa
    Finsinger, Paola
    Chisini, Marta
    Gentilini, Fabiana
    PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 939 - 946
  • [4] Alternating bortezomib-dexamethasone and lenalidomide- dexamethasone in patients with newly diagnosed multiple myeloma aged over 75 years
    Yokoyama, Akihiro
    Kada, Akiko
    Kagoo, Toshiya
    Hidake, Michihiro
    Iida, Hiroatsu
    Miyata, Yasuhiko
    Saito, Akiko M.
    Sawamura, Morio
    Komeno, Takuya
    Sunami, Kazutaka
    Takezako, Naoki
    Nagai, Hirokazu
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2022, 84 (01): : 80 - 90
  • [5] BLOOD DISTRIBUTION OF SUBCUTANEOUS BORTEZOMIB AND ITS KINETICS IN MULTIPLE MYELOMA PATIENTS
    Osawa, Takashi
    Naito, Takafumi
    Mino, Yasuaki
    Kawakami, Junichi
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S89 - S89
  • [6] CLINICAL BENEFIT OF BORTEZOMIB I IMIDS IN PATIENTS OVER 75 YEARS WITH MULTIPLE MYELOMA IN HABITUAL CLINICAL PRACTICE. RESTROPECTIVE AND UNICENTRIC STUDY
    Gonzalez, Y.
    Cruz, D.
    Moret, C.
    Osca, G.
    Tuset, E.
    Gallardo
    HAEMATOLOGICA, 2018, 103 : 112 - 113
  • [7] Triplet versus doublet therapy in multiple myeloma patients over 75 years.
    Alam, Zuhair
    Grewal, Ravleen
    Girnius, Saulius Kazmiems
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma
    Moreau, Philippe
    Coiteux, Valerie
    Hulin, Cyrille
    Leleu, Xavier
    van de Velde, Helgi
    Acharya, Milin
    Harousseau, Jean-Luc
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (12): : 1908 - 1911
  • [9] EFFICACY AND SAFETY STUDY OF SUBCUTANEOUS INJECTION OF BORTEZOMIB IN THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA
    Fu, C.
    Liu, H.
    Wu, D.
    Xue, S.
    Li, W.
    Wu, Q.
    Gu, B.
    Jin, S.
    Zhu, X.
    Zhao, S.
    Xin, X.
    Ma, L.
    Sun, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S452 - S452
  • [10] Subcutaneous Bortezomib, Melphalan and Prednisone in Elderly Newly Diagnosed Multiple Myeloma Patients
    Herbaux, Charles
    Joao, Cristina M.
    Plocque, Alexia
    Richez, Valentine
    Gay, Francesca
    Renaud, Loic
    Legros, Laurence
    Garderet, Laurent
    Ikhlef, Souhila
    Pegourie, Brigitte
    Escoffre-Barbe, Martine
    Royer, Bruno
    Voillat, Laurent
    Hulin, Cyrille
    Banos, Anne
    Voog, Eric G.
    Karlin, Lionel
    Stoppa, Anne-Marie
    Benboubker, Lotfi
    Zweegman, Sonja
    De Jongh, Eva
    Abildgaard, Niels
    Le Du, Katell
    Jurczyszyn, Artur J.
    Moreau, Philippe
    Facon, Thierry
    Caillot, Denis
    Terpos, Evangelos
    Leleu, Xavier
    BLOOD, 2014, 124 (21)
12345